Literature DB >> 11106585

Different subtypes of human lung adenocarcinoma caused by different etiological factors. Evidence from p53 mutational spectra.

T Hashimoto1, Y Tokuchi, M Hayashi, Y Kobayashi, K Nishida, S Hayashi, Y Ishikawa, K Nakagawa, J Hayashi, E Tsuchiya.   

Abstract

Human lung adenocarcinomas are only relatively weakly associated with tobacco smoke, and other etiological factors need to be clarified. These may also vary with the histopathology. Because the p53 mutation status (frequency and spectrum) of a carcinoma can provide clues to causative agents, we subclassified 113 adenocarcinomas into five cell types: hobnail, columnar/cuboidal, mixed, polygonal, and goblet (54, 23, 18, 13, and 5, respectively) and investigated relationships with p53 mutations and smoking history. In the hobnail cell type, a low mutational frequency (37%) and a high proportion of transitions (65%), especially G:C to A:T transitions at CpG dinucleotides (45%) associated with spontaneous mutations, were found with a weak relation to tobacco smoke. In contrast, a high mutation frequency (70%) with a higher proportion of transversions (50%), especially G:C to T:A (44%) on the nontranscribed DNA strand, caused by exogenous carcinogenic agents like tobacco smoke, were observed for the columnar cell type, as with squamous cell carcinomas. These results indicate that two major subtypes of lung adenocarcinoma exist, one probably caused by tobacco smoke, and the other possibly due to spontaneous mutations. For the prevention of lung adenocarcinomas, in addition to stopping tobacco smoking, the elucidation of endogenous mechanisms is important.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106585      PMCID: PMC1885779          DOI: 10.1016/s0002-9440(10)64851-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

Review 1.  Clinical implications of the p53 tumor-suppressor gene.

Authors:  C C Harris; M Hollstein
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

Review 2.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

3.  DNA strand bias in the repair of the p53 gene in normal human and xeroderma pigmentosum group C fibroblasts.

Authors:  M K Evans; B G Taffe; C C Harris; V A Bohr
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

4.  Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung.

Authors:  Y Kishimoto; Y Murakami; M Shiraishi; K Hayashi; T Sekiya
Journal:  Cancer Res       Date:  1992-09-01       Impact factor: 12.701

5.  p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking.

Authors:  H Suzuki; T Takahashi; T Kuroishi; M Suyama; Y Ariyoshi; T Takahashi; R Ueda
Journal:  Cancer Res       Date:  1992-02-01       Impact factor: 12.701

Review 6.  DNA methylation and mutation.

Authors:  R Holliday; G W Grigg
Journal:  Mutat Res       Date:  1993-01       Impact factor: 2.433

Review 7.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

8.  Estimates of the worldwide incidence of eighteen major cancers in 1985.

Authors:  D M Parkin; P Pisani; J Ferlay
Journal:  Int J Cancer       Date:  1993-06-19       Impact factor: 7.396

9.  p53 mutations in lung cancers from non-smoking atomic-bomb survivors.

Authors:  Y Takeshima; T Seyama; W P Bennett; M Akiyama; S Tokuoka; K Inai; K Mabuchi; C E Land; C C Harris
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

10.  Case-control study for lung cancer and cigarette smoking in Osaka, Japan: comparison with the results from Western Europe.

Authors:  T Sobue; T Suzuki; I Fujimoto; M Matsuda; O Doi; T Mori; K Furuse; M Fukuoka; T Yasumitsu; O Kuwahara
Journal:  Jpn J Cancer Res       Date:  1994-05
View more
  4 in total

1.  Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes.

Authors:  Ja-Lok Ku; Kyung-Hee Kim; Jin-Sung Choi; You-Kyung Jeon; Sung-Hee Kim; Young-Kyoung Shin; Tae-You Kim; Yung-Jue Bang; Woo Ho Kim; Jae-Gahb Park
Journal:  Cell Oncol (Dordr)       Date:  2011-02-02       Impact factor: 6.730

2.  Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells.

Authors:  Susan M Dougherty; Williard Mazhawidza; Aimee R Bohn; Krista A Robinson; Kathleen A Mattingly; Kristy A Blankenship; Mary O Huff; William G McGregor; Carolyn M Klinge
Journal:  Endocr Relat Cancer       Date:  2006-03       Impact factor: 5.678

3.  Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma.

Authors:  M Sonobe; T Manabe; H Wada; F Tanaka
Journal:  Br J Cancer       Date:  2005-08-08       Impact factor: 7.640

4.  Combined effects of asbestos and cigarette smoke on the development of lung adenocarcinoma: different carcinogens may cause different genomic changes.

Authors:  Kentaro Inamura; Hironori Ninomiya; Kimie Nomura; Eiju Tsuchiya; Yukitoshi Satoh; Sakae Okumura; Ken Nakagawa; Ayako Takata; Norihiko Kohyama; Yuichi Ishikawa
Journal:  Oncol Rep       Date:  2014-06-13       Impact factor: 3.906

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.